Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Biomolecules & Therapeutics|March 10, 2022
Strategies for Manipulating T Cells in Cancer ImmunotherapyHyang-Mi LeeBiomolecules & Therapeutics|June 6, 2024
Engineered T Cell Receptor for Cancer ImmunotherapySo Won Lee, Hyang-Mi LeeJournal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Rare development of Foxp3+ thymocytes in the CD4+CD8+ subsetHyang Mi Lee, Chyi-Song HsiehPharmaceuticals (Basel, Switzerland)|July 28, 2026
Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer ImmunotherapySu-Jin Kang, Hyang-Mi LeeJournal of Microbiology and Biotechnology|June 21, 2019
Synthetic Bacteria for TherapeuticsPhuong Vo, Hyang-Mi Lee, Dokyun NaBiomedicines|September 23, 2022
Inflammatory Cytokine: An Attractive Target for Cancer TreatmentHyang-Mi Lee, Hye-Jin Lee, Ji-Eun ChangBiochemical and Biophysical Research Communications|May 26, 2026
Leveraging CRISPR/Cas9 for optimized adoptive T cell therapies: From molecular engineering to clinical manufacturingJi-Hyeon Kim, Hyo Jung Cho, Hyang-Mi LeeFEBS Letters|October 9, 2016
Glutathione upregulates cAMP signalling via G protein alpha 2 during the development of Dictyostelium discoideumHyang-Mi Lee, Ji-Sun Kim, Sa-Ouk KangThe Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|February 24, 2022
The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open stateHyang Mi Lee, Sang June Hahn, Bok Hee ChoiBiological & Pharmaceutical Bulletin|June 5, 2010
Inhibitory action of fluvoxamine on Kv1.5 currentsHyang Mi Lee, Sang June Hahn, Bok Hee ChoiPageof 7